CLEO Diagnostics Ltd (COV) Ownership - Who Owns CLEO Diagnostics Ltd?
CLEO Diagnostics Ltd (COV) Ownership Overview
- 3.77% Insiders
- 96.23% Public Companies and Individual Investors
The ownership structure of CLEO Diagnostics Ltd (AU:COV) stock is a mix of institutional, retail, and individual investors. , 3.77% is owned by Insiders, and 96.23% is owned by Public Companies and Individual Investors.
The ownership structure of CLEO Diagnostics Ltd (AU:COV) stock is a mix of institutional, retail, and individual investors. , 3.77% is owned by Insiders, and 96.23% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Richard Allman | 1,727,273 | Insider | 1.21% | 357,546 |
| Lucinda Joan Frawley | 1,500,000 | Insider | 1.05% | 310,500 |
| Thomas William Jobling | 1,500,000 | Insider | 1.05% | 310,500 |
| Andrew Nicholas Stephens | 636,364 | Insider | 0.45% | 131,727 |
FAQ
What percentage of CLEO Diagnostics Ltd (AU:COV) stock is held by retail investors?
According to the latest TipRanks data, approximately 96.23% of CLEO Diagnostics Ltd (AU:COV) stock is held by public companies and individual investors.
Who owns the most shares of CLEO Diagnostics Ltd (AU:COV)?
Richard Allman owns the most shares of CLEO Diagnostics Ltd (AU:COV).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.